Exicure, a biotechnology company, announced board changes effective June 30, 2026. Director Ham Jung Kyu resigned, and the board expanded from five to six members. Two new directors—Go Jin Young and Han Eui Seok—were appointed as Class III directors. The company also formed a Compensation Committee, with Han as Chair and Dongho Lee as a member.
View Full Filing (SEC EDGAR)